WP_LEPTIN_SIGNALING_PATHWAY | Return to index | ||||||||
Order | Gene | Description | ref_hepatocyte | HepG2 | HepG2.C3A | HuH.7 | SNU475 | THLE | liver |
1 | RPS6 | 40S ribosomal protein S6 | [1] | [2] | [3] | [4] | [5] | [6] | [7] |
2 | RHOA | Transforming protein RhoA | [8] | -0.55[9] | -0.85[10] | -0.89[11] | -0.81[12] | -0.13[13] | -1.03[14] |
3 | CDC42 | Cell division control protein 42 homolog | [15] | -0.43[16] | 0.48[17] | -0.79[18] | -0.12[19] | -0.62[20] | -1.78[21] |
4 | RAC1 | Ras-related C3 botulinum toxin substrate 1 | [22] | 0.00[23] | -0.14[24] | 0.31[25] | 0.43[26] | 0.64[27] | -0.67[28] |
5 | EIF4EBP1 | Eukaryotic translation initiation factor 4E-binding protein 1 | [29] | -0.60[30] | -0.73[31] | -0.38[32] | -2.89[33] | -1.11[34] | -1.30[35] |
6 | CFL2 | Cofilin-2 | [36] | -0.04[37] | -1.31[38] | 0.05[39] | 0.38[40] | -0.63[41] | 0.22[42] |
7 | AKT1 | RAC-alpha serine/threonine-protein kinase | [43] | 0.47[44] | 0.44[45] | -0.91[46] | 0.36[47] | 0.61[48] | 0.05[49] |
8 | STAT3 | Signal transducer and activator of transcription 3 | [50] | 0.94[51] | -0.36[52] | 0.11[53] | 0.65[54] | 0.16[55] | 2.71[56] |
9 | MAP2K1 | Dual specificity mitogen-activated protein kinase kinase 1 | [57] | -0.53[58] | -0.67[59] | -0.35[60] | -0.13[61] | 0.60[62] | -0.89[63] |
10 | MAP2K2 | Dual specificity mitogen-activated protein kinase kinase 2 | [64] | 0.45[65] | 0.32[66] | 0.92[67] | -0.43[68] | 0.28[69] | -1.40[70] |
11 | BCL2L1 | Bcl-2-like protein 1 | [71] | 2.53[72] | 2.11[73] | 2.81[74] | -0.20[75] | 0.41[76] | -0.52[77] |
12 | IL1RN | Interleukin-1 receptor antagonist protein | [78] | -3.26[79] | -0.32[80] | -8.77[81] | [82] | -8.09[83] | -0.30[84] |
13 | BAX | Apoptosis regulator BAX | [85] | 0.72[86] | 0.12[87] | -0.60[88] | -1.19[89] | -0.58[90] | -3.66[91] |
14 | CCND1 | G1/S-specific cyclin-D1 | [92] | 3.45[93] | 1.13[94] | 1.70[95] | 2.29[96] | 1.04[97] | 1.35[98] |
15 | IKBKG | NF-kappa-B essential modulator | [99] | -0.49[100] | -0.16[101] | -2.67[102] | -0.44[103] | -1.42[104] | -0.30[105] |
16 | PTPN11 | Tyrosine-protein phosphatase non-receptor type 11 | [106] | 0.84[107] | 1.46[108] | 1.15[109] | 1.30[110] | 2.16[111] | 1.56[112] |
17 | GRB2 | Growth factor receptor-bound protein 2 | [113] | 1.59[114] | 1.62[115] | 1.48[116] | 0.96[117] | 1.11[118] | 0.60[119] |
18 | STAT1 | Signal transducer and activator of transcription 1-alpha/beta | [120] | 0.32[121] | -0.40[122] | 0.44[123] | 2.94[124] | 0.90[125] | 1.25[126] |
19 | KHDRBS1 | KH domain-containing, RNA-binding, signal transduction-associated protein 1 | 1.47[127] | 1.36[128] | 2.26[129] | 1.62[130] | 1.66[131] | -0.42[132] | |
20 | BAD | Bcl2-associated agonist of cell death | [133] | -1.28[134] | -0.95[135] | -2.17[136] | -0.65[137] | -0.02[138] | -1.12[139] |
21 | SHC1 | SHC-transforming protein 1 | [140] | 1.56[141] | 1.97[142] | 1.78[143] | 3.06[144] | 2.78[145] | 1.08[146] |
22 | RELA | Transcription factor p65 | [147] | 0.53[148] | 0.22[149] | 0.09[150] | 0.36[151] | 0.49[152] | -0.58[153] |
23 | RAF1 | RAF proto-oncogene serine/threonine-protein kinase | [154] | 0.33[155] | 0.93[156] | 1.93[157] | 0.23[158] | 1.32[159] | 1.40[160] |
24 | JAK1 | Tyrosine-protein kinase JAK1 | [161] | 0.91[162] | 0.59[163] | 0.50[164] | 1.04[165] | 1.91[166] | 1.83[167] |
25 | EIF4E | Eukaryotic translation initiation factor 4E | [168] | 0.53[169] | 1.55[170] | 0.65[171] | 0.14[172] | 1.39[173] | 0.47[174] |
26 | HRAS | GTPase HRas | [175] | -0.61[176] | -1.13[177] | -2.18[178] | -0.54[179] | -0.52[180] | -2.36[181] |
27 | SOCS3 | Suppressor of cytokine signaling 3 | [182] | -3.75[183] | -3.96[184] | -2.51[185] | -0.39[186] | -1.23[187] | 0.43[188] |
28 | MAPK1 | Mitogen-activated protein kinase 1 | [189] | 2.10[190] | 2.43[191] | 2.00[192] | 2.26[193] | 2.14[194] | 2.08[195] |
29 | GSK3A | Glycogen synthase kinase-3 alpha | [196] | 1.02[197] | 0.95[198] | 0.78[199] | 0.49[200] | 1.48[201] | -1.53[202] |
30 | PTK2 | Focal adhesion kinase 1 | [203] | 1.13[204] | 1.81[205] | 1.93[206] | 2.36[207] | 1.79[208] | 1.06[209] |
31 | PTPN1 | Tyrosine-protein phosphatase non-receptor type 1 | [210] | 1.51[211] | 1.37[212] | 0.63[213] | 2.23[214] | 1.76[215] | -0.01[216] |
32 | MAPK14 | Mitogen-activated protein kinase 14 | [217] | 1.87[218] | 2.13[219] | 1.44[220] | 2.09[221] | 1.80[222] | 1.58[223] |
33 | PRKAA1 | 5'-AMP-activated protein kinase catalytic subunit alpha-1 | [224] | 0.31[225] | 1.79[226] | 3.04[227] | 1.87[228] | 2.38[229] | 2.36[230] |
34 | PIK3R1 | Phosphatidylinositol 3-kinase regulatory subunit alpha | [231] | -0.08[232] | 0.23[233] | 1.06[234] | 2.48[235] | 2.21[236] | 3.30[237] |
35 | KPNA4 | Importin subunit alpha-3 | [238] | 1.32[239] | 1.54[240] | 1.51[241] | 1.98[242] | 2.28[243] | 1.52[244] |
36 | MAPK8 | Mitogen-activated protein kinase 8 | [245] | -1.05[246] | 0.55[247] | -0.84[248] | -0.49[249] | -0.41[250] | -0.21[251] |
37 | SOS1 | Son of sevenless homolog 1 | [252] | 0.29[253] | 2.02[254] | 1.26[255] | 1.26[256] | 0.72[257] | 0.84[258] |
38 | ELK1 | ETS domain-containing protein Elk-1 | [259] | 0.08[260] | -1.86[261] | 0.29[262] | 0.68[263] | 1.50[264] | 0.13[265] |
39 | ROCK1 | Rho-associated protein kinase 1 | [266] | -0.56[267] | 1.16[268] | 1.67[269] | 1.77[270] | 1.35[271] | 1.88[272] |
40 | PTEN | Phosphatidylinositol 3,4,5-trisphosphate 3-phosphatase and dual-specificity protei | -0.14[273] | 1.44[274] | 1.38[275] | -0.15[276] | 1.33[277] | 2.78[278] | |
41 | ERBB2 | Receptor tyrosine-protein kinase erbB-2 | [279] | 2.76[280] | 1.78[281] | 2.69[282] | 1.67[283] | 1.50[284] | 0.45[285] |
42 | NFKB1 | Nuclear factor NF-kappa-B p105 subunit | [286] | 1.06[287] | 0.93[288] | 0.46[289] | 0.16[290] | 1.30[291] | 0.75[292] |
43 | LEPR | Leptin receptor | [293] | -4.20[294] | -1.34[295] | 1.07[296] | -0.89[297] | -0.60[298] | 4.53[299] |
44 | ACACB | Acetyl-CoA carboxylase 2 | [300] | -0.48[301] | 0.69[302] | 0.55[303] | -1.36[304] | -0.84[305] | 4.48[306] |
45 | PIK3R2 | Phosphatidylinositol 3-kinase regulatory subunit beta | [307] | 2.27[308] | 2.68[309] | 3.03[310] | 1.12[311] | 1.91[312] | 0.01[313] |
46 | ROCK2 | Rho-associated protein kinase 2 | [314] | 1.87[315] | 3.30[316] | 1.51[317] | 3.05[318] | 1.04[319] | 2.22[320] |
47 | RPS6KA1 | Ribosomal protein S6 kinase alpha-1 | [321] | [322] | [323] | [324] | [325] | [326] | [327] |
48 | CISH | Cytokine-inducible SH2-containing protein | [328] | -2.51[329] | -2.13[330] | -2.19[331] | -2.23[332] | -3.45[333] | 1.40[334] |
49 | MAPK3 | Mitogen-activated protein kinase 3 | [335] | 2.24[336] | 2.48[337] | 2.26[338] | 0.83[339] | 1.08[340] | -0.74[341] |
50 | GSK3B | Glycogen synthase kinase-3 beta | [342] | 1.66[343] | 1.49[344] | 1.80[345] | 2.23[346] | 2.28[347] | 1.46[348] |
51 | STAT5B | Signal transducer and activator of transcription 5B | [349] | 1.75[350] | 1.57[351] | 2.01[352] | 1.96[353] | 1.33[354] | 1.92[355] |
52 | CHUK | Inhibitor of nuclear factor kappa-B kinase subunit alpha | [356] | 1.30[357] | 2.71[358] | 2.41[359] | 1.06[360] | 2.10[361] | 1.81[362] |
53 | SRC | Proto-oncogene tyrosine-protein kinase Src | [363] | 3.42[364] | 3.60[365] | 2.33[366] | 2.81[367] | 2.22[368] | -0.55[369] |
54 | SOCS2 | Suppressor of cytokine signaling 2 | [370] | -0.41[371] | -2.76[372] | -4.78[373] | 1.07[374] | -4.43[375] | 1.95[376] |
55 | SP1 | Transcription factor Sp1 | [377] | 2.21[378] | 2.65[379] | 3.45[380] | 3.08[381] | 2.99[382] | 2.45[383] |
56 | PLCG1 | 1-phosphatidylinositol 4,5-bisphosphate phosphodiesterase gamma-1 | 3.88[384] | 3.70[385] | 2.76[386] | 3.23[387] | 2.95[388] | 0.64[389] | |
57 | IKBKB | Inhibitor of nuclear factor kappa-B kinase subunit beta | [390] | 0.91[391] | 1.17[392] | 1.01[393] | 0.67[394] | 0.99[395] | 1.48[396] |
58 | SH2B1 | SH2B adapter protein 1 | [397] | 1.54[398] | 2.45[399] | 1.85[400] | 0.73[401] | 1.65[402] | 0.39[403] |
59 | MTOR | Serine/threonine-protein kinase mTOR | [404] | 2.93[405] | 4.13[406] | 3.44[407] | 3.09[408] | 3.40[409] | 3.75[410] |
60 | PDE3B | cGMP-inhibited 3',5'-cyclic phosphodiesterase B | [411] | 0.84[412] | 2.00[413] | 1.98[414] | -0.97[415] | -1.18[416] | 3.17[417] |
61 | RPS6KB1 | Ribosomal protein S6 kinase beta-1 | [418] | [419] | [420] | [421] | [422] | [423] | [424] |
62 | IL1B | Interleukin-1 beta | [425] | -8.30[426] | -7.98[427] | -3.92[428] | -3.18[429] | 2.64[430] | -4.90[431] |
63 | IRS1 | Insulin receptor substrate 1 | [432] | 2.48[433] | 2.12[434] | 3.28[435] | 2.12[436] | 1.93[437] | 2.41[438] |
64 | ACACA | Acetyl-CoA carboxylase 1 | [439] | 2.85[440] | 3.38[441] | 4.03[442] | 2.99[443] | 2.41[444] | 3.65[445] |
65 | FYN | Tyrosine-protein kinase Fyn | [446] | 1.34[447] | -7.07[448] | 1.23[449] | 1.88[450] | 3.64[451] | 1.27[452] |
66 | NCOA1 | Nuclear receptor coactivator 1 | [453] | 0.86[454] | 1.62[455] | 1.55[456] | 2.20[457] | 1.88[458] | 2.95[459] |
67 | CREB1 | Cyclic AMP-responsive element-binding protein 1 | [460] | 2.12[461] | 3.47[462] | 3.69[463] | 2.95[464] | 3.12[465] | 2.64[466] |
68 | FOXO1 | Forkhead box protein O1 | [467] | 2.09[468] | 1.95[469] | 1.82[470] | 1.59[471] | 3.83[472] | 3.39[473] |
69 | ESR1 | Estrogen receptor | [474] | -6.91[475] | [476] | -5.46[477] | -3.76[478] | -5.79[479] | 2.70[480] |
70 | SOCS7 | Suppressor of cytokine signaling 7 | [481] | 3.54[482] | 3.32[483] | 3.66[484] | 2.83[485] | 2.78[486] | 2.22[487] |
71 | PLCG2 | 1-phosphatidylinositol 4,5-bisphosphate phosphodiesterase gamma-2 | -0.89[488] | -6.44[489] | 0.74[490] | -2.32[491] | -0.94[492] | 3.02[493] | |
72 | JAK2 | Tyrosine-protein kinase JAK2 | [494] | 0.62[495] | 0.81[496] | 0.10[497] | 1.17[498] | 2.00[499] | 3.00[500] |
73 | PRKAA2 | 5'-AMP-activated protein kinase catalytic subunit alpha-2 | [501] | 3.43[502] | 4.07[503] | 3.83[504] | 3.45[505] | 1.72[506] | 2.15[507] |
74 | REL | Proto-oncogene c-Rel | [508] | -0.12[509] | 1.84[510] | 1.51[511] | 0.56[512] | 0.94[513] | 2.64[514] |
75 | NOS3 | Nitric oxide synthase, endothelial | [515] | 5.16[516] | 2.46[517] | 1.66[518] | 0.47[519] | 2.03[520] | 3.07[521] |
76 | LEP | Leptin | [522] | -0.93[523] | 0.24[524] | -0.57[525] | -0.44[526] | -1.54[527] | 2.60[528] |